Carna Biosciences, Inc. Logo

Carna Biosciences, Inc.

Clinical-stage biopharma developing small molecule kinase inhibitors.

4572 | T

Overview

Corporate Details

ISIN(s):
JP3220550002
LEI:
Country:
Japan
Address:
神戸市中央区港島南町一丁目5番5号

Description

Carna Biosciences, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of small molecule kinase inhibitors. The company focuses on creating therapies for diseases with significant unmet medical needs, particularly in oncology and autoimmune disorders. Carna Biosciences operates through two core segments: a drug discovery business that advances its proprietary pipeline of drug candidates, and a drug discovery support business. The support division provides the global research community with a comprehensive portfolio of products and services, including a wide array of kinase proteins, biochemical and cell-based screening, and profiling services to accelerate pharmaceutical research and development.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-11 07:45
訂正有価証券届出書(組込方式)
Japanese 347.4 KB
2025-09-12 08:46
訂正有価証券届出書(組込方式)
Japanese 325.6 KB
2025-08-07 02:46
訂正有価証券届出書(組込方式)
Japanese 243.9 KB
2025-08-07 02:45
訂正有価証券届出書(組込方式)
Japanese 244.0 KB
2025-08-07 02:43
確認書
Japanese 8.8 KB
2025-08-07 02:42
半期報告書-第23期(2025/01/01-2025/12/31)
Japanese 358.3 KB
2025-07-11 08:47
有価証券届出書(組込方式)
Japanese 393.6 KB
2025-07-11 08:46
有価証券届出書(組込方式)
Japanese 393.6 KB
2025-07-11 08:45
有価証券届出書(組込方式)
Japanese 392.8 KB
2025-03-28 02:41
臨時報告書
Japanese 28.5 KB
2025-03-26 02:11
内部統制報告書-第22期(2024/01/01-2024/12/31)
Japanese 24.5 KB
2025-03-26 02:10
確認書
Japanese 8.7 KB
2025-03-26 02:08
有価証券報告書-第22期(2024/01/01-2024/12/31)
Japanese 1.3 MB
2024-09-25 08:39
臨時報告書
Japanese 122.5 KB
2024-08-08 02:51
確認書
Japanese 8.7 KB

Automate Your Workflow. Get a real-time feed of all Carna Biosciences, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Carna Biosciences, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Carna Biosciences, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Astria Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapies for allergic and immunologic diseases.
United States of America
ATXS
ATAI Life Sciences N.V. Logo
Develops psychedelic-inspired therapies for mental health disorders.
United States of America
ATAI
Atea Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing oral antiviral therapies for serious viral diseases.
United States of America
AVIR
Athira Pharma, Inc. Logo
Biopharma firm developing small molecule therapeutics for neurodegenerative diseases.
United States of America
ATHA
ATOSSA THERAPEUTICS, INC. Logo
Clinical-stage biopharmaceutical company developing oncology medicines for breast cancer.
United States of America
ATOS
aTYR PHARMA INC Logo
Develops medicines based on tRNA synthetase biology for fibrosis and inflammation.
United States of America
ATYR
Aura Biosciences, Inc. Logo
Develops Virus-Like Drug Conjugates as targeted therapies for solid tumors.
United States of America
AURA
Aurinia Pharmaceuticals Inc. Logo
Biopharmaceutical company developing therapies for severe autoimmune diseases.
United States of America
AUPH
AURORA CANNABIS INC Logo
Global producer and distributor of cannabis for medical and recreational markets.
United States of America
ACB
Autolus Therapeutics plc Logo
Biopharmaceutical company developing programmed T cell therapies for cancer and autoimmune diseases.
United States of America
AUTL

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.